UNSPSC 51241877: Lidocaine/neomycin/polymyxin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE900. This VA Drug Class (DE900) classifies this compound as belonging to the group DERMATOLOGICALS, TOPICAL OTHER.

UNSPSC 51241877 Lidocaine/neomycin/polymyxin, a Commodity code, shows a fundamental mismatch between its nominal scope and recent state and local procurement activity. The code's name suggests pharmaceutical topical antibiotic products, yet the two recent opportunities tagged to it involve liquid aluminum sulfate for wastewater treatment and medical first aid supplies — neither of which align with the code's stated product category. State and local procurement offices appear to be applying this code inconsistently or incorrectly to unrelated commodity acquisitions, creating noise rather than signal for vendors targeting the intended product line.

The mismatch limits actionable insight from the recent-opportunities record. The City of Austin's IFB 2200 CSH1061 (due August 25, 2026) procures 179,200 gallons annually of NSF-approved liquid aluminum sulfate at 47%–49% concentration for phosphorus removal at a wastewater treatment facility, with local and small business preference discounts available; and the City of Tampa Fire Rescue's ITB 25-P-00157 (bid opening April 9, 2025) covers 32 medical and first aid supply line items including bandages, antiseptic sprays, and pain relievers with SLBE and U-WMBE set-aside discounts. Neither represents genuine procurement demand under the lidocaine/neomycin/polymyxin code. Vendors pursuing topical antibiotic products for state and local use should monitor alternative UNSPSC codes or consult procurement offices directly to identify properly classified solicitations; relying on this code's recent-opportunities stream will yield few relevant matches.